Log in

NASDAQ:NXTCNextCure News Headlines

$17.88
-0.30 (-1.65 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.55
Now: $17.88
$18.45
50-Day Range
$18.18
MA: $25.69
$34.54
52-Week Range
$16.04
Now: $17.88
$109.00
Volume710,200 shs
Average Volume445,147 shs
Market Capitalization$492.06 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.05

Headlines

NextCure (NASDAQ NXTC) News Headlines

Source:
DateHeadline
BRIEF-Nextcure Initiates Phase 1/2 Clinical Study Of NC410, A Novel Immunomedicine, For Solid Tumors - ReutersBRIEF-Nextcure Initiates Phase 1/2 Clinical Study Of NC410, A Novel Immunomedicine, For Solid Tumors - Reuters
www.reuters.com - July 7 at 7:03 PM
NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors - GlobeNewswireNextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors - GlobeNewswire
www.globenewswire.com - July 7 at 7:03 PM
NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid TumorsNextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors
finance.yahoo.com - July 7 at 7:03 PM
Short Interest in NextCure Inc (NASDAQ:NXTC) Increases By 41.5%Short Interest in NextCure Inc (NASDAQ:NXTC) Increases By 41.5%
www.americanbankingnews.com - July 6 at 1:10 AM
NextCure, Inc. (NXTC): Are Hedge Funds Right About This Stock? - Yahoo FinanceNextCure, Inc. (NXTC): Are Hedge Funds Right About This Stock? - Yahoo Finance
finance.yahoo.com - June 27 at 10:31 PM
NextCure, Inc. (NXTC): Are Hedge Funds Right About This Stock?NextCure, Inc. (NXTC): Are Hedge Funds Right About This Stock?
finance.yahoo.com - June 27 at 10:31 PM
NextCure Inc (NASDAQ:NXTC) Given Average Recommendation of "Buy" by AnalystsNextCure Inc (NASDAQ:NXTC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 22 at 6:16 AM
Benzingas Top Upgrades, Downgrades For June 1, 2020 - BenzingaBenzinga's Top Upgrades, Downgrades For June 1, 2020 - Benzinga
www.benzinga.com - June 1 at 12:50 PM
7 High-Risk Stocks For Market Gamblers - Yahoo Finance7 High-Risk Stocks For Market Gamblers - Yahoo Finance
finance.yahoo.com - May 29 at 10:54 PM
NextCure Inc. (NXTC) Reports Biomarker Data and Updated Clinical Results from Phase 1 Portion of NC318 Clinical Trial - StreetInsider.comNextCure Inc. (NXTC) Reports Biomarker Data and Updated Clinical Results from Phase 1 Portion of NC318 Clinical Trial - StreetInsider.com
www.streetinsider.com - May 29 at 10:54 PM
NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting - GlobeNewswireNextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting - GlobeNewswire
www.globenewswire.com - May 29 at 10:54 PM
NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual MeetingNextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - May 29 at 12:53 PM
Analysts Expect XBI Will Reach $134 - NasdaqAnalysts Expect XBI Will Reach $134 - Nasdaq
www.nasdaq.com - May 15 at 8:59 AM
NextCure Inc (NXTC) Beats Q1 Earnings and Revenue EstimatesNextCure Inc (NXTC) Beats Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 8 at 12:17 AM
NextCure EPS beats by $0.77, beats on revenueNextCure EPS beats by $0.77, beats on revenue
seekingalpha.com - May 7 at 7:16 PM
NextCure Reports First Quarter 2020 Financial ResultsNextCure Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 7 at 7:16 PM
NextCure to Present at BofA Securities Virtual Health Care ConferenceNextCure to Present at BofA Securities Virtual Health Care Conference
finance.yahoo.com - May 6 at 12:02 PM
NextCure Delays 2 Clinical Trials Due to CoronavirusNextCure Delays 2 Clinical Trials Due to Coronavirus
www.fool.com - April 14 at 6:56 PM
NextCure delays launch of NC318 and NC410 trials amid COVID-19NextCure delays launch of NC318 and NC410 trials amid COVID-19
seekingalpha.com - April 13 at 9:26 AM
NextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 PandemicNextCure Provides Update on Clinical Trial Activities Due to Impact of COVID-19 Pandemic
finance.yahoo.com - April 13 at 9:26 AM
NextCure to Present at the 19th Annual Needham Virtual Healthcare ConferenceNextCure to Present at the 19th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 8 at 9:09 AM
NextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of DirectorsNextCure Announces Appointment of Veteran Oncology Executive Garry Nicholson to its Board of Directors
finance.yahoo.com - March 30 at 7:52 AM
Why You Shouldnt Bet Against NextCure (NXTC) StockWhy You Shouldn't Bet Against NextCure (NXTC) Stock
www.nasdaq.com - March 26 at 1:39 PM
Why You Shouldn't Bet Against NextCure (NXTC) StockWhy You Shouldn't Bet Against NextCure (NXTC) Stock
finance.yahoo.com - March 26 at 1:39 PM
NextCure EPS misses by $0.12, beats on revenueNextCure EPS misses by $0.12, beats on revenue
seekingalpha.com - March 12 at 5:26 PM
NextCure Reports Fourth Quarter and Full Year 2019 Financial ResultsNextCure Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 12 at 5:26 PM
NextCure (NXTC) Presents At Cowen Health Care Conference - SlideshowNextCure (NXTC) Presents At Cowen Health Care Conference - Slideshow
seekingalpha.com - March 6 at 1:24 PM
NextCure to Present at the 40th Annual Cowen Health Care ConferenceNextCure to Present at the 40th Annual Cowen Health Care Conference
finance.yahoo.com - February 25 at 12:40 PM
NextCure Inc.NextCure Inc.
www.barrons.com - January 31 at 12:19 AM
NextCure IncNextCure Inc
www.bloomberg.com - January 27 at 12:11 AM
What Does the Future Hold for Nextcure?What Does the Future Hold for Nextcure?
www.fool.com - January 18 at 12:22 PM
NextCure to Present at the 38th Annual J.P. Morgan Healthcare ConferenceNextCure to Present at the 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 6:25 PM
Stocks To Watch: Key 2020 Events And CatalystsStocks To Watch: Key 2020 Events And Catalysts
seekingalpha.com - January 1 at 5:18 PM
Is NextCure, Inc. (NXTC) A Good Stock To Buy ?Is NextCure, Inc. (NXTC) A Good Stock To Buy ?
finance.yahoo.com - December 16 at 7:29 AM
NextCure to Present at Piper Jaffray 31st Annual Healthcare ConferenceNextCure to Present at Piper Jaffray 31st Annual Healthcare Conference
finance.yahoo.com - November 26 at 11:47 AM
Is NextCure a Buy?Is NextCure a Buy?
www.fool.com - November 23 at 12:31 PM
NextCure Announces Closing of Public OfferingNextCure Announces Closing of Public Offering
finance.yahoo.com - November 19 at 6:41 PM
NextCure prices stock offering at $36.75NextCure prices stock offering at $36.75
seekingalpha.com - November 15 at 10:26 AM
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGenes Blood Cancer Drug Gets ApprovalThe Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
finance.yahoo.com - November 15 at 10:26 AM
NextCure Announces Pricing of Public Offering of Common StockNextCure Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - November 15 at 12:24 AM
NextCures Big Rise And Fall, And Other Headlines: The Good, Bad And Ugly Of BiopharmaNextCure's Big Rise And Fall, And Other Headlines: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - November 13 at 5:34 PM
NextCure, Inc. (NXTC)NextCure, Inc. (NXTC)
seekingalpha.com - November 12 at 7:42 PM
NextCure -7.8% after filing to offer 3.2M sharesNextCure -7.8% after filing to offer 3.2M shares
seekingalpha.com - November 12 at 7:42 PM
Analyst Trims NextCure Price Target Following SITC Presentation, Still Sees Big UpsideAnalyst Trims NextCure Price Target Following SITC Presentation, Still Sees Big Upside
finance.yahoo.com - November 12 at 7:42 PM
NextCure Announces Proposed Public Offering of Common StockNextCure Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 12 at 7:42 PM
NextCure EPS misses by $0.02, misses on revenueNextCure EPS misses by $0.02, misses on revenue
seekingalpha.com - November 12 at 9:41 AM
NextCure Reports Third Quarter 2019 Financial ResultsNextCure Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 12 at 9:41 AM
NextCure Stock Collapses After New Cancer Drug DataNextCure Stock Collapses After New Cancer Drug Data
finance.yahoo.com - November 11 at 5:51 PM
Heres Why NextCure Crashed TodayHere's Why NextCure Crashed Today
www.nasdaq.com - November 11 at 12:51 PM
Why Investors Are Pumping the Brakes on NextCure’s Cancer TreatmentWhy Investors Are Pumping the Brakes on NextCure’s Cancer Treatment
www.msn.com - November 11 at 12:51 PM
This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.